- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/08 - Bridged systems
Patent holdings for IPC class C07D 491/08
Total number of patents in this class: 677
10-year publication summary
|
55
|
38
|
34
|
45
|
38
|
31
|
53
|
54
|
44
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4814 |
20 |
| Merck Sharp & Dohme LLC | 3702 |
18 |
| F. Hoffmann-La Roche AG | 7832 |
15 |
| Hoffmann-La Roche Inc. | 3665 |
15 |
| Pfizer Inc. | 3353 |
14 |
| Amgen Inc. | 4327 |
14 |
| Merck Patent GmbH | 5716 |
13 |
| Vertex Pharmaceuticals Incorporated | 1600 |
13 |
| Epizyme, Inc. | 359 |
13 |
| Genentech, Inc. | 4052 |
12 |
| Zevra Therapeutics, Inc. | 108 |
10 |
| Boehringer Ingelheim International GmbH | 4552 |
9 |
| Novartis AG | 10376 |
8 |
| Rigel Pharmaceuticals, Inc. | 510 |
8 |
| Janssen Pharmaceutica N.V. | 3245 |
7 |
| Shionogi & Co., Ltd. | 833 |
7 |
| Skyhawk Therapeutics, Inc. | 143 |
7 |
| Takeda Pharmaceutical Company Limited | 2720 |
6 |
| Bodor Laboratories, Inc. | 58 |
6 |
| H. Lundbeck A/S | 1244 |
6 |
| Other owners | 456 |